{"DataElement":{"publicId":"6764301","version":"1","preferredName":"Mixed Phenotype Acute Leukemia Phenotype Description Type","preferredDefinition":"The response to a question asking about the type of MPAL phenotype a patient is diagnosed with.","longName":"MPAL_PHEN_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6764295","version":"1","preferredName":"Mixed Phenotype Acute Leukemia Phenotype Description","preferredDefinition":"An acute leukemia of ambiguous lineage.  It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage._The outward appearance of the individual. It is the product of interactions between genes and between the genotype and the environment. This includes the killer phenotype, characteristic of YEASTS._A written or verbal account, representation, statement, or explanation of something.","longName":"6764292v1.0:6764293v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6764292","version":"1","preferredName":"Mixed Phenotype Acute Leukemia","preferredDefinition":"An acute leukemia of ambiguous lineage.  It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage.","longName":"C82179","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia","conceptCode":"C82179","definition":"An acute leukemia of ambiguous lineage.  It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"896A4759-9977-4A59-E053-F662850AEEAC","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-21","modifiedBy":"ONEDATA","dateModified":"2019-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6764293","version":"1","preferredName":"Phenotype Description","preferredDefinition":"The outward appearance of the individual. It is the product of interactions between genes and between the genotype and the environment. This includes the killer phenotype, characteristic of YEASTS.:A written or verbal account, representation, statement, or explanation of something.","longName":"C16977:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phenotype","conceptCode":"C16977","definition":"The assemblage of traits or outward appearance of an individual. It is the product of interactions between genes and between genes and the environment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"896A4759-9988-4A59-E053-F662850AEEAC","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-21","modifiedBy":"ONEDATA","dateModified":"2019-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"896A4759-9999-4A59-E053-F662850AEEAC","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-21","modifiedBy":"SETRAKIN","dateModified":"2019-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6764296","version":"1","preferredName":"Phenotype Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6764296v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T-Myeloid","valueDescription":"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified","ValueMeaning":{"publicId":"4538437","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified","longName":"4538437","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for MLL translocation and t(9;22)(q34;q11.2) translocation.  The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, T/Myeloid","conceptCode":"C82213","definition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"058F579C-8D6D-3DA1-E050-BB89AD436D0B","latestVersionIndicator":"Yes","beginDate":"2014-10-16","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-16","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8994F357-0E8D-2DA0-E053-F662850A0E92","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"B-Myeloid","valueDescription":"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified","ValueMeaning":{"publicId":"4538435","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified","longName":"4538435","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for MLL translocation and t(9;22)(q34;q11.2) translocation.  The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, B/Myeloid","conceptCode":"C82212","definition":"A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"058F579C-8D47-3DA1-E050-BB89AD436D0B","latestVersionIndicator":"Yes","beginDate":"2014-10-16","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-16","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89958F5F-F6FB-3121-E053-F662850A583D","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"B-T","valueDescription":"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified","ValueMeaning":{"publicId":"6338189","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified","longName":"6338189","preferredDefinition":"A very rare mixed phenotype acute leukemia, not otherwise specified in which the blasts show clear-cut evidence of both B-cell and T-cell lineage. (WHO 2017)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, B/T","conceptCode":"C151992","definition":"A very rare mixed phenotype acute leukemia in which the blasts show clear-cut evidence of both B-cell and T-cell lineage but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F2889D3-6AD1-431C-E053-F662850A5844","latestVersionIndicator":"Yes","beginDate":"2018-06-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89958F5F-F710-3121-E053-F662850A583D","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"B-T-Myeloid","valueDescription":"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present","ValueMeaning":{"publicId":"6769005","version":"1","preferredName":"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present","longName":"6769005","preferredDefinition":"A finding indicating the presence of blasts with evidence of trilineage (B-cell, T-cell, and myeloid lineage) assignment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present","conceptCode":"C151986","definition":"A finding indicating the presence of blasts with evidence of trilineage (B-cell, T-cell, and myeloid lineage) assignment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89958F5F-F71D-3121-E053-F662850A583D","latestVersionIndicator":"Yes","beginDate":"2019-05-23","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89958F5F-F738-3121-E053-F662850A583D","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-23","modifiedBy":"ONEDATA","dateModified":"2019-05-23","deletedIndicator":"No"},{"value":"B/myeloid","valueDescription":"B/Myeloid","ValueMeaning":{"publicId":"6764300","version":"1","preferredName":"B/Myeloid","longName":"6764300","preferredDefinition":"B/Myeloid","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"896A26EB-8FF0-4A4F-E053-F662850AC689","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-21","modifiedBy":"ONEDATA","dateModified":"2019-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E3CF64-4ADC-4C30-E053-4EBD850A6576","beginDate":"2021-04-26","endDate":null,"createdBy":"LEEW","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"},{"value":"B/T lymphoid","valueDescription":"B/T lymphoid","ValueMeaning":{"publicId":"7642264","version":"1","preferredName":"B/T lymphoid","longName":"7642264","preferredDefinition":"B/T lymphoid","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0E3CF64-4AE6-4C30-E053-4EBD850A6576","latestVersionIndicator":"Yes","beginDate":"2021-04-26","endDate":null,"createdBy":"LEEW","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C0E3CF64-4AFF-4C30-E053-4EBD850A6576","beginDate":"2021-04-26","endDate":null,"createdBy":"LEEW","dateCreated":"2021-04-26","modifiedBy":"ONEDATA","dateModified":"2021-04-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"896A26EB-8F71-4A4F-E053-F662850AC689","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-21","modifiedBy":"LEEW","dateModified":"2021-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"If yes, MPAL Phenotype:","type":"Preferred Question Text","description":"If yes, MPAL Phenotype:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"MPAL Phenotype:","url":null,"context":"COG"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Mixed phenotype acute leukemia subtype:","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Which lineages are present?","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Mixed phenotype acute leukemia immunopheno type:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"896A26EB-9013-4A4F-E053-F662850AC689","latestVersionIndicator":"Yes","beginDate":"2019-05-21","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2019-05-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":"2023.9.7 AQT added per ticket request CADSR0002816. ak 2022.11.17 AQT added for ticket request CADSR0001705. ak","unresolvedIssues":null,"deletedIndicator":"No"}}